C. Sander

Discipline

Economies et finances (4) Histoire, Philosophie et Sociologie des sciences (1)

Type de document

Articles (17)

Co-auteur

Date

Source

Mot-clé

Patients (10) Patients (10) Treatment (7) Human beings (7) Expression (7) Social sciences (6) Atrial fibrillation (6) recherche (5) cancer (5) Cancer (5) Research (5) Cancer (5) Research (5) Utilization (5) thérapie (4) programme (4) analyse (4) maladie (4) méthode (4) Blockades (4) Databases (4) Inhibitors (4) Methods (4) Databases (4) Antigenic determinants (4) Databases (4) Tumors (4) Therapeutics (4) T cells (4) Melanoma (4)

Documents écrit par C. Sander (17) | parle de C. Sander (0)

Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry
Wern Yew Ding et al. (1 mai 2022)
Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC‐EHRA EURObservational research programme in atrial fibrillation general long‐term registry
Pitt‐kerby T et al. (19 mars 2022)
Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry
Marco Proietti et al. (déc. 2021)
COVID19 Disease Map, a computational knowledge repository of virus-host interaction mechanisms.
M. Ostaszewski et al.
Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry
Cyril Zakine et al. (1 juil. 2019)
Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry
Giuseppe Boriani et al. (1 mai 2018)
Oncogenic Signaling Pathways in The Cancer Genome Atlas.
F. Sanchez-Vega et al. (5 avr. 2018)
Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas.
G.P. Way et al. (2018)
A Multi-Method Approach for Proteomic Network Inference in 11 Human Cancers.
Y. Şenbabaoğlu et al. (2016)
Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma.
F. Chen et al. (2016)
The SAMe-TT2R2 score and quality of anticoagulation in atrial fibrillation: a simple aid to decision-making on who is suitable (or not) for vitamin K antagonists
Wern Yew Ding et al. (29 avr. 2015)
Systematic identification of cancer driving signaling pathways based on mutual exclusivity of genomic alterations.
Ö. Babur et al. (26 févr. 2015)
Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy.
E. Oricchio et al. (30 juin 2014)
PD-1 and Tim-3 regulate the expansion of tumor antigen-specific CD8⁺ T cells induced by melanoma vaccines.
J. Fourcade et al. (2014)
CD8(+) T cells specific for tumor antigens can be rendered dysfunctional by the tumor microenvironment through upregulation of the inhibitory receptors BTLA and PD-1.
J. Fourcade et al. (2012)
Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients.
J. Fourcade et al. (2010)
PD-1 is a regulator of NY-ESO-1-specific CD8+ T cell expansion in melanoma patients.
J. Fourcade et al. (2009)